VNA 438
Alternative Names: VNA-438Latest Information Update: 12 Feb 2024
At a glance
- Originator Vandria
- Class Hepatoprotectants; Small molecules
- Mechanism of Action Autophagy stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Non-alcoholic steatohepatitis
Most Recent Events
- 16 Jan 2024 Early research in Non-alcoholic steatohepatitis in Switzerland (unspecified route) prior to January 2024 (Vandria pipeline, January 2024)